Skip to contentScholarGate
LibraryBookshelfDeskReview StudioAssistant
Sign in
On this page
IntuitionHow it worksWhen to use itStrengths & limitationsCommon pitfallsApplicationsFrequently asked🔒 Read the full methodSourcesRelated methods
Cite this pageSpotted an issue on this page? Report or suggest a fix →
Home›Epidemiology›Risk-Adjusted Case-Crossover Design
Process / pipelineClinical / epidemiology

Risk-Adjusted Case-Crossover Design

Also known as: adjusted case-crossover study, covariate-adjusted case-crossover, risk-controlled case-crossover, case-crossover with risk adjustment

The risk-adjusted case-crossover design is a self-matched epidemiological method that compares a person's exposure during a brief hazard window immediately preceding an acute event to their exposure during one or more control windows from the same individual, while formally accounting for time-varying or time-fixed covariates that could confound the exposure-event relationship. By using each case as their own control, stable individual-level confounders are automatically cancelled, while covariate adjustment handles residual time-varying risks.

ScholarGate
  1. Process / pipeline
  2. v1
  3. 2 Sources
  4. PUBLISHED
Cite this page →
Tools & resources
Download slides
Learn & explore

Read the full method

Members only

Sign in with a free account to read this section.

Sign in

Method map

The neighbourhood of related methods — select a node to explore.

Risk-adjusted case-crossover design
Case-control studyCase-crossover designPropensity Score MatchingRisk-adjusted cohort stu…

When to use it

Use a risk-adjusted case-crossover design when the research question concerns the short-term, transient effect of a time-varying exposure on an acute outcome, and when electronic or registry data allow reliable within-person exposure reconstruction across multiple time windows. It is particularly well-suited to pharmacoepidemiology (e.g., drug-triggered arrhythmias), environmental epidemiology (air pollution and emergency admissions), and injury research (alcohol and road traffic crashes). Do not use it when the exposure is essentially time-invariant (e.g., a genetic variant), when the outcome is chronic or delayed (e.g., developing a tumour over years), when accurate time-stamped exposure records are unavailable, or when the induction period between exposure and outcome is too long to capture in a feasible hazard window.

Strengths & limitations

Strengths
  • Complete control of all time-invariant individual-level confounders through the self-matched design, without requiring their measurement.
  • Formal covariate adjustment removes residual confounding from time-varying factors that differ between case and control windows.
  • Well-suited to large administrative and electronic health record databases where within-person longitudinal data are readily available.
  • Efficient use of data — every case contributes its own controls, eliminating the need for a separate unaffected comparator group.
  • Produces internally valid transient exposure effect estimates even in the presence of unmeasured stable individual characteristics.
Limitations
  • Cannot estimate effects of chronic or slowly varying exposures; the design is limited to transient, time-varying risk factors.
  • Secular trends in exposure can induce bias if control periods are not selected using a time-stratified or bidirectional symmetric strategy.
  • Relies on the availability of accurate, time-stamped exposure and covariate data; misclassification within person-time is more consequential than in between-person designs.
  • The case-crossover framework assumes that the outcome is acute and that the induction period is short and well-defined — assumptions that are difficult to verify empirically.

Frequently asked

How is the risk-adjusted case-crossover design different from a standard case-crossover design?

The standard case-crossover design relies solely on the self-matching to control confounding, which eliminates only time-invariant individual characteristics. The risk-adjusted version additionally models time-varying covariates — such as concurrent drug use, temperature, or season — as explicit terms in the conditional logistic regression, removing residual confounding that the self-match alone cannot handle.

Which referent selection strategy should I use?

The time-stratified referent selection strategy is generally recommended because it avoids secular-trend bias by selecting control days from the same calendar stratum (e.g., same month and year) as the case day. Bidirectional symmetric designs are an acceptable alternative. Unidirectional strategies (only earlier or only later control periods) should be avoided unless you can demonstrate that exposure is trend-free over the study period.

Why is conditional logistic regression used instead of standard logistic regression?

Conditional logistic regression conditions on the matched set formed by each individual's case and control periods, which correctly accounts for the within-person pairing. Standard logistic regression would ignore the matching structure, produce invalid standard errors, and fail to cancel the time-invariant confounders that the self-matched design is designed to eliminate.

Can I apply this design to drug safety studies using administrative data?

Yes — the risk-adjusted case-crossover design is a mainstay of pharmacoepidemiology with administrative claims data. Each patient who experiences an acute outcome serves as their own control by comparing drug exposure in the hazard window to control windows earlier in their claims history. Time-varying covariates such as concurrent drug fills, calendar season, and hospitalisation history can be extracted from the same database and included as adjusters.

What sample size do I need?

Sample size depends on the rarity of the outcome, the expected odds ratio, and the within-person exposure variability. Because each case contributes its own controls, the effective sample size is the number of cases — not the total population. Simulations or published formulas for matched case-control studies can be adapted; a minimum of several dozen cases is typically needed to detect moderate effect sizes, and hundreds of cases are preferred for stable adjusted estimates.

Sources

  1. Maclure, M. (1991). The case-crossover design: a method for studying transient effects on the risk of acute events. American Journal of Epidemiology, 133(2), 144–153. DOI: 10.1093/oxfordjournals.aje.a115853 ↗
  2. Navidi, W. (1998). Bidirectional case-crossover designs for exposures with time trends. Biometrics, 54(2), 596–605. DOI: 10.2307/3109766 ↗

How to cite this page

ScholarGate. (2026, June 3). Risk-Adjusted Case-Crossover Design. ScholarGate. https://scholargate.app/en/epidemiology/risk-adjusted-case-crossover-design

Related methods

Case-control studyCase-crossover designPropensity Score MatchingRisk-adjusted cohort study

Which method?

Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.

  • Case-control studyEpidemiology↔ compare
  • Case-crossover designEpidemiology↔ compare
  • Propensity Score MatchingResearch Statistics↔ compare
  • Risk-adjusted cohort studyEpidemiology↔ compare
Compare side by side →

Similar methods

Case-crossover designMatched Case-Crossover DesignProspective Case-Crossover DesignMulticenter Case-Crossover DesignBayesian Case-Crossover DesignMeta-analytic case-crossover designRisk-adjusted Nested Case-ControlCase-Time-Control Design

Related reference concepts

Case-Control StudyStudy Matching and StratificationRisk Ratios and Odds Ratios: Computation and InterpretationObservational Study DesignQuasi-Experimental and Natural Experiment DesignCase-Control and Cohort Studies in Outbreak Investigation

Spotted an issue on this page? Report or suggest a fix →

ScholarGate — Risk-adjusted case-crossover design (Risk-Adjusted Case-Crossover Design). Retrieved 2026-07-20 from https://scholargate.app/en/epidemiology/risk-adjusted-case-crossover-design · Dataset: https://doi.org/10.5281/zenodo.20539026
Quick facts
Originator
Malcolm Maclure (case-crossover base); extensions incorporating covariate risk adjustment developed in subsequent pharmacoepidemiology literature
Year
1991 (base design); risk-adjustment extensions from mid-1990s onward
Type
Observational analytic epidemiological design
DataType
Individual-level event data with time-stamped exposure and covariate records
Subfamily
Clinical / epidemiology
Related methods
Case-control studyCase-crossover designPropensity Score MatchingRisk-adjusted cohort study
ScholarGate

A content-first reference library for research methods — what each one is, how it works, and where it comes from.

Open data (CC-BY)

Explore

  • Library
  • Search the library…
  • Browse by field
  • Fields
  • Journey
  • Compare
  • Which method?

Reference

  • Subjects
  • Atlas
  • Glossary
  • Methodology
  • Philosophy

Your tools

  • Bookshelf
  • Desk
  • Chat

Company

  • About
  • Pricing
  • Contact
  • Suggest a method

Entries are compiled from published sources for reference. Verifying the accuracy and suitability of any information for your own use remains your responsibility.

© 2026 ScholarGate · A research-method reference library
  • Privacy
  • Cookies
  • Terms
  • Delete account